FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1973294973> ?p ?o ?g. }

• W1973294973 abstract "The Fat Mass and Obesity-Associated Protein (FTO) gene rs9939609 single nucleotide polymorphism (SNP) has been associated with obesity, metabolic syndrome, insulin resistance (IR), and type 2 diabetes mellitus in the general population. The aim of our study was to examine for the first time the association of the rs9939609 polymorphism with metabolic disturbances, liver disease and virologic response to hepatitis C virus (HCV) therapy with pegylated-interferon-alpha plus ribavirin (pegIFNα/RBV) in human immunodeficiency virus (HIV)/HCV coinfected patients.We carried out a cross-sectional study in 261 patients, of whom 178 were subsequently treated with pegIFNα/RBV therapy. FTO rs9939609 and IFNL3 rs12980275 polymorphisms were genotyped by GoldenGate®. The main outcomes were: 1) metabolic disturbances: insulin resistance (homeostatic model assessment (HOMA-IR)) and overweight (body mass index (BMI)); 2) liver disease (Metavir score): significant fibrosis (F ≥2) and steatosis (>10% fatty hepatocytes); and 3) virologic response to HCV treatment: sustained virologic response (SVR).The rs9939609 AA genotype was associated with higher values of BMI (adjusted arithmetic mean ratio (aAMR) = 1.08; 95% confidence interval (95%CI) = 1.03 to 1.14; P = 0.002) and HOMA-IR (aAMR = 1.32; 95%CI = 1.03 to 1.69; P = 0.027). Patients with an rs9939609 AA genotype had higher likelihoods of achieving values of BMI ≥27.5 kg/m2 (adjusted odds ratio (aOR) = 3.46; 95%CI =1.17 to 10.21; P = 0.024), HOMA-IR ≥2.5 (aOR = 2.09; 95%CI = 1.02 to 4.32; P = 0.045), significant fibrosis (aOR = 2.34; 95%CI =1.02 to 5.36; P = 0.045) and steatosis (aOR = 3.65; 95%CI = 1.29 to 10.36; P = 0.015). The rs9939609 AT/AA genotype decreased the likelihood of achieving SVR (aOR = 0.58; 95%CI = 0.34 to 0.99; P = 0.044). A decision tree was performed with the genotypes of HCV, IFNL3 and FTO. The incorporation of rs9939609 significantly improves the prediction of SVR (P <0.05). The overall accuracy was 68.2%.Patients carrying the unfavourable AT/AA genotype of rs9939609 polymorphism had higher odds of metabolic disturbances and a lower likelihood of achieving successful virologic response to HCV therapy." @default.
• W1973294973 created "2016-06-24" @default.
• W1973294973 creator A5011012640 @default.
• W1973294973 creator A5015136634 @default.
• W1973294973 creator A5019656796 @default.
• W1973294973 creator A5022172440 @default.
• W1973294973 creator A5028332401 @default.
• W1973294973 creator A5037679984 @default.
• W1973294973 creator A5055406905 @default.
• W1973294973 creator A5066862011 @default.
• W1973294973 creator A5071073433 @default.
• W1973294973 creator A5079952452 @default.
• W1973294973 creator A5083181351 @default.
• W1973294973 creator A5086251157 @default.
• W1973294973 date "2014-11-03" @default.
• W1973294973 modified "2023-10-17" @default.
• W1973294973 title "FTOrs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients" @default.
• W1973294973 cites W1551592846 @default.
• W1973294973 cites W1937192900 @default.
• W1973294973 cites W1965158257 @default.
• W1973294973 cites W1969178186 @default.
• W1973294973 cites W1972019208 @default.
• W1973294973 cites W1976966203 @default.
• W1973294973 cites W1987923869 @default.
• W1973294973 cites W1995489318 @default.
• W1973294973 cites W2003460252 @default.
• W1973294973 cites W2004372194 @default.
• W1973294973 cites W2005125597 @default.
• W1973294973 cites W2009160696 @default.
• W1973294973 cites W2020257925 @default.
• W1973294973 cites W2025651303 @default.
• W1973294973 cites W2028335133 @default.
• W1973294973 cites W2028623783 @default.
• W1973294973 cites W2029689583 @default.
• W1973294973 cites W2031859820 @default.
• W1973294973 cites W2035126508 @default.
• W1973294973 cites W2036550935 @default.
• W1973294973 cites W2037332452 @default.
• W1973294973 cites W2048548385 @default.
• W1973294973 cites W2052887965 @default.
• W1973294973 cites W2057211436 @default.
• W1973294973 cites W2058817056 @default.
• W1973294973 cites W2061592062 @default.
• W1973294973 cites W2066811407 @default.
• W1973294973 cites W2075836716 @default.
• W1973294973 cites W2076069695 @default.
• W1973294973 cites W2082817821 @default.
• W1973294973 cites W2097073538 @default.
• W1973294973 cites W2097660065 @default.
• W1973294973 cites W2103638317 @default.
• W1973294973 cites W2108303181 @default.
• W1973294973 cites W2121819193 @default.
• W1973294973 cites W2122764811 @default.
• W1973294973 cites W2132015866 @default.
• W1973294973 cites W2132432704 @default.
• W1973294973 cites W2137354005 @default.
• W1973294973 cites W2141578651 @default.
• W1973294973 cites W2141695788 @default.
• W1973294973 cites W2146329405 @default.
• W1973294973 cites W2148864053 @default.
• W1973294973 cites W2158063642 @default.
• W1973294973 cites W2158546156 @default.
• W1973294973 cites W2160234571 @default.
• W1973294973 cites W2161060550 @default.
• W1973294973 cites W2162072565 @default.
• W1973294973 cites W2330040314 @default.
• W1973294973 cites W96201458 @default.
• W1973294973 doi "https://doi.org/10.1186/s12916-014-0198-y" @default.
• W1973294973 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4224698" @default.
• W1973294973 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25367448" @default.
• W1973294973 hasPublicationYear "2014" @default.
• W1973294973 type Work @default.
• W1973294973 sameAs 1973294973 @default.
• W1973294973 citedByCount "3" @default.
• W1973294973 countsByYear W19732949732016 @default.
• W1973294973 countsByYear W19732949732018 @default.
• W1973294973 countsByYear W19732949732020 @default.
• W1973294973 crossrefType "journal-article" @default.
• W1973294973 hasAuthorship W1973294973A5011012640 @default.
• W1973294973 hasAuthorship W1973294973A5015136634 @default.
• W1973294973 hasAuthorship W1973294973A5019656796 @default.
• W1973294973 hasAuthorship W1973294973A5022172440 @default.
• W1973294973 hasAuthorship W1973294973A5028332401 @default.
• W1973294973 hasAuthorship W1973294973A5037679984 @default.
• W1973294973 hasAuthorship W1973294973A5055406905 @default.
• W1973294973 hasAuthorship W1973294973A5066862011 @default.
• W1973294973 hasAuthorship W1973294973A5071073433 @default.
• W1973294973 hasAuthorship W1973294973A5079952452 @default.
• W1973294973 hasAuthorship W1973294973A5083181351 @default.
• W1973294973 hasAuthorship W1973294973A5086251157 @default.
• W1973294973 hasBestOaLocation W19732949731 @default.
• W1973294973 hasConcept C126322002 @default.
• W1973294973 hasConcept C134018914 @default.
• W1973294973 hasConcept C156957248 @default.
• W1973294973 hasConcept C203014093 @default.
• W1973294973 hasConcept C2522874641 @default.
• W1973294973 hasConcept C2776175330 @default.
• W1973294973 hasConcept C2776408679 @default.
• W1973294973 hasConcept C2776455275 @default.
• W1973294973 hasConcept C2776461080 @default.

• next